Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus

BMC Neurosci. 2010 Mar 26:11:42. doi: 10.1186/1471-2202-11-42.

Abstract

Background: Midkine (MK), a member of the heparin-binding growth factor family, which includes MK and pleiotrophin, is known to possess neurotrophic and neuroprotective properties in the central nervous system. Previous studies have shown that MK is an effective neuroprotective agent in reducing retinal degeneration caused by excessive light and decreasing hippocampal neuronal death in ischemic gerbil brain. The present study was undertaken to investigate whether MK acts as an anticonvulsant in kainic acid (KA)-induced seizure in mouse and blocks KA-mediated neuronal cell death in hippocampus.

Results: Increased expression of MK was found in hippocampus of mouse following seizures induced by intracerebroventricular injection of KA, and MK expression was found in glial fibrillary acidic protein (GFAP)-positive astrocytes. Concurrent injection of MK and KA attenuated KA-induced seizure activity and cell death of hippocampal neurons including pyramidal cells and glutamic acid decarboxylase 67 (GAD67)-positive GABAergic interneurons in the CA3 and hilar area.

Conclusion: The results of the present study indicate that MK functions as an anticonvulsant and neuroprotective agent in hippocampus during KA-induced seizures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology*
  • Anticonvulsants / therapeutic use
  • Astrocytes / drug effects
  • Astrocytes / metabolism
  • Biomarkers / metabolism
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cytokines / pharmacology*
  • Cytokines / therapeutic use
  • Disease Models, Animal
  • Epilepsy / chemically induced
  • Epilepsy / drug therapy*
  • Epilepsy / physiopathology
  • Epilepsy, Temporal Lobe / chemically induced
  • Epilepsy, Temporal Lobe / drug therapy
  • Epilepsy, Temporal Lobe / physiopathology
  • Glial Fibrillary Acidic Protein / metabolism
  • Glutamate Decarboxylase / metabolism
  • Hippocampus / drug effects*
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Injections, Intraventricular
  • Interneurons / drug effects
  • Interneurons / metabolism
  • Kainic Acid / antagonists & inhibitors
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Midkine
  • Nerve Degeneration / drug therapy*
  • Nerve Degeneration / physiopathology
  • Nerve Degeneration / prevention & control
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Neurotoxins / antagonists & inhibitors
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / metabolism
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Anticonvulsants
  • Biomarkers
  • Cytokines
  • Glial Fibrillary Acidic Protein
  • Neuroprotective Agents
  • Neurotoxins
  • Midkine
  • gamma-Aminobutyric Acid
  • Glutamate Decarboxylase
  • glutamate decarboxylase 1
  • Kainic Acid